VCs Eye Europe's Drug Cabinet: Index, Orion Share Designs on Clinical Stage Compounds
This article was originally published in Start Up
Executive Summary
Two new investment vehicles have been formed to take advantage of the relative immaturity of Europe's life sciences industry. Index Ventures and Orion Health Care Equity Partners both see opportunities abound in Europe's biopharmaceutical start-ups, but they have different approaches.